These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21637010)

  • 41. A high-affinity recombinant antibody permits rapid and sensitive direct detection of myeloperoxidase.
    McDonnell B; Hearty S; Finlay WJ; O'Kennedy R
    Anal Biochem; 2011 Mar; 410(1):1-6. PubMed ID: 20920456
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiac point of care testing: a focused review of current National Academy of Clinical Biochemistry guidelines and measurement platforms.
    Christenson RH; Azzazy HM
    Clin Biochem; 2009 Feb; 42(3):150-7. PubMed ID: 18929551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of Tethered Enzymes as a Platform Technology for Rapid Analyte Detection.
    Cohen R; Lata JP; Lee Y; Hernández JC; Nishimura N; Schaffer CB; Mukai C; Nelson JL; Brangman SA; Agrawal Y; Travis AJ
    PLoS One; 2015; 10(11):e0142326. PubMed ID: 26605916
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Silicon nanowire biosensor and its applications in disease diagnostics: a review.
    Zhang GJ; Ning Y
    Anal Chim Acta; 2012 Oct; 749():1-15. PubMed ID: 23036462
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Microfluidic designs and techniques using lab-on-a-chip devices for pathogen detection for point-of-care diagnostics.
    Foudeh AM; Fatanat Didar T; Veres T; Tabrizian M
    Lab Chip; 2012 Sep; 12(18):3249-66. PubMed ID: 22859057
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Point-of-care diagnostics: market trends and growth drivers.
    Rajan A; Glorikian H
    Expert Opin Med Diagn; 2009 Jan; 3(1):1-4. PubMed ID: 23495959
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The diagnostic utility of cardiac biomarkers in dialysis patients.
    Wang AY; Wai-Kei Lam C
    Semin Dial; 2012 Jul; 25(4):388-96. PubMed ID: 22748194
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of electrochemical immunosensors towards point of care diagnostics.
    Wan Y; Su Y; Zhu X; Liu G; Fan C
    Biosens Bioelectron; 2013 Sep; 47():1-11. PubMed ID: 23542064
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiac troponin I and troponin T: recent players in the field of myocardial markers.
    Chapelle JP
    Clin Chem Lab Med; 1999 Jan; 37(1):11-20. PubMed ID: 10094373
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A multiplexable, microfluidic platform for the rapid quantitation of a biomarker panel for early ovarian cancer detection at the point-of-care.
    Shadfan BH; Simmons AR; Simmons GW; Ho A; Wong J; Lu KH; Bast RC; McDevitt JT
    Cancer Prev Res (Phila); 2015 Jan; 8(1):37-48. PubMed ID: 25388014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Point-of-care diagnostics: an advancing sector with nontechnical issues.
    Huckle D
    Expert Rev Mol Diagn; 2008 Nov; 8(6):679-88. PubMed ID: 18999920
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lab-on-a-Chip Platforms for Detection of Cardiovascular Disease and Cancer Biomarkers.
    Wu J; Dong M; Santos S; Rigatto C; Liu Y; Lin F
    Sensors (Basel); 2017 Dec; 17(12):. PubMed ID: 29258216
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Opportunities and challenges for the application of microfluidic technologies in point-of-care veterinary diagnostics.
    Busin V; Wells B; Kersaudy-Kerhoas M; Shu W; Burgess ST
    Mol Cell Probes; 2016 Oct; 30(5):331-341. PubMed ID: 27430150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of emergency department patient classification by point-of-care and central laboratory methods for cardiac troponin I.
    Bock JL; Singer AJ; Thode HC
    Am J Clin Pathol; 2008 Jul; 130(1):132-5. PubMed ID: 18550482
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Point of Care Ultrasound: A WFUMB Position Paper.
    Dietrich CF; Goudie A; Chiorean L; Cui XW; Gilja OH; Dong Y; Abramowicz JS; Vinayak S; Westerway SC; Nolsøe CP; Chou YH; Blaivas M
    Ultrasound Med Biol; 2017 Jan; 43(1):49-58. PubMed ID: 27472989
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Point of care testing: The impact of nanotechnology.
    Syedmoradi L; Daneshpour M; Alvandipour M; Gomez FA; Hajghassem H; Omidfar K
    Biosens Bioelectron; 2017 Jan; 87():373-387. PubMed ID: 27589400
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pushing the limits of electrochemistry toward challenging applications in clinical diagnosis, prognosis, and therapeutic action.
    Yáñez-Sedeño P; Campuzano S; Pingarrón JM
    Chem Commun (Camb); 2019 Feb; 55(18):2563-2592. PubMed ID: 30688320
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quartz crystal microbalance biosensors: prospects for point-of-care diagnostics.
    Prakrankamanant P
    J Med Assoc Thai; 2014 Apr; 97 Suppl 4():S56-64. PubMed ID: 24851566
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.